Author

James O. Lindsay

European Crohn’s and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease
European Crohn’s and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease

James O. Lindsay  et al.

RISANKIZUMAB VERSUS USTEKINUMAB FOR PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM THE PHASE 3B SEQUENCE STUDY
RISANKIZUMAB VERSUS USTEKINUMAB FOR PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM THE PHASE 3B SEQUENCE STUDY

James O. Lindsay  et al.

UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care

James O. Lindsay  et al.

EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY
EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY

James O. Lindsay  et al.

Item 21 - 24 / 24
1
2